Evidence map›Paper›PMID 34493665›Full record

ArticleProceedings of the National Academy of Sciences of the United States of America2021

Prediction of arrhythmia susceptibility through mathematical modeling and machine learning.

Meera Varshneya, Xueyan Mei, Eric A Sobie

Open access · greenAbstract read
In one paragraph

Article in Proceedings of the National Academy of Sciences of the United States of America, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 16 papers.

0numbers the graph read from it
0cells of the map it votes in
16citing papers in PubMed
4.9field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

16 citing papers in PubMed, 38 citations in OpenAlex.

  1. Review
  2. Population Modeling Approach for Human Cardiac Arrhythmia Risk Prediction.Circulation. Arrhythmia and electrophysiology · 2026
    Article
  3. Article
  4. Article
  5. Article
  6. Review
  7. Review
  8. Review
  9. Article
  10. Article
  11. Article
  12. Review
  13. Article
  14. Quantitative approaches to drug safety: The 2022 PSP special issue.CPT: pharmacometrics & systems pharmacology · 2022
    Article
  15. Benefits of SGLT2 inhibitors in arrhythmias.Frontiers in cardiovascular medicine · 2022
    Review
  16. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 1 institution in 1 country.

Meera VarshneyaDepartment of Pharmacological Sciences, Icahn School of Medicine at Mount Sinai, New York, NY 10029.ORCID 0000-0003-0548-5820
Xueyan MeiBiomedical Engineering and Imaging Institute, Icahn School of Medicine at Mount Sinai, New York, NY 10029.ORCID 0000-0001-7224-7318
Eric A SobieDepartment of Pharmacological Sciences, Icahn School of Medicine at Mount Sinai, New York, NY 10029; eric.sobie@mssm.edu.ORCID 0000-0001-7327-8538
Icahn School of Medicine at Mount Sinai · US

Funding

Multiscale modeling to map cardiac electrophysiology between speciesU01HL136297 · NHLBI · ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI · PI CHRISTINI, DAVID J., SOBIE, ERIC A · 2017 to 2021
$3.2M
Combining Systems Pharmacology Modeling With Machine Learning To Identify Sub-Populations At Risk Of Drug-Induced Torsades de PointesF31HL149358 · NHLBI · ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI · PI VARSHNEYA, MEERA · 2019 to 2021
$77k
NHLBI NIH HHS F31 HL149358NHLBI NIH HHS U01 HL136297
6 · The paper itself

Abstract

At present, the QT interval on the electrocardiographic (ECG) waveform is the most common metric for assessing an individual's susceptibility to ventricular arrhythmias, with a long QT, or, at the cellular level, a long action potential duration (APD) considered high risk. However, the limitations of this simple approach have long been recognized. Here, we sought to improve prediction of arrhythmia susceptibility by combining mechanistic mathematical modeling with machine learning (ML). Simulations with a model of the ventricular myocyte were performed to develop a large heterogenous population of cardiomyocytes (

Indexed as

Action PotentialsAnti-Arrhythmia AgentsArrhythmias, CardiacDisease SusceptibilityElectrophysiological PhenomenaForecastingHeart VentriclesHumansLong QT SyndromeMachine LearningModels, TheoreticalMuscle CellsMyocytes, CardiacPotassiumPotassium ChannelsAnti-Arrhythmia AgentsPotassiumPotassium Channelsarrhythmiaselectrophysiologymachine learningmathematical modelingpopulation modeling

Identifiers

PMID34493665
PMCPMC8449417
OpenAlexW3196581067

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.